In type-two diabetic KKAy mouse model, supplementation of PSO regulated gut microbiota, improved hypertriglyceridemia, and ameliorated insulin resistance by enhancing the liver expression of phosphoinositide-3 kinase (PI3K) and protein kinase B (AKT) pathways [15,21]. This evidence concerns the gene AKT1 and hypertriglyceridemia.